2026 NPPES data Allergy & Immunology (Internal Medicine) Physician NPI 1881024891 M.D.
Verify on CMS →

SCHWETA ARAKALI, M.D.

Allergy & Immunology (Internal Medicine) Physician in ALLENTOWN, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
214
Medicare Part D claims · 57 beneficiaries · Allergy & Immunology (Internal Medicine) Physician avg: 798
Generic prescribing
71%
generic claims · 29% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.4K
57 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SCHWETA ARAKALI, M.D. filed 214 Medicare Part D claims in 2023 as a Allergy & Immunology (Internal Medicine) Physician in ALLENTOWN, Pennsylvania, prescribing 71% generic.

214
Part D claims, 2023
71%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SCHWETA ARAKALI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

214 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SCHWETA ARAKALI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SCHWETA ARAKALI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 11/13/2013

NPI 1881024891

Primary specialty

Allergy & Immunology (Internal Medicine) Physician

Niche

520 US NPIs in this specialty

Medicare Part D claims

214 73% vs specialty avg

2023 prescription claims

Specialty avg: 798

Specialty distribution in Pennsylvania

How Allergy & Immunology (Internal Medicine) Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Allergy & Immunology (Internal Medicine) Physician share within Pennsylvania

1. Allergy & Immunology (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology (Internal Medicine) Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Allergy & Immunology (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy & Immunology (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Allergy & Immunology (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy & Immunology (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SCHWETA ARAKALI, M.D. is a Allergy & Immunology (Internal Medicine) Physician provider practicing in ALLENTOWN, Pennsylvania, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1881024891. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SCHWETA ARAKALI, M.D. appears in the CMS NPPES registry as a Allergy & Immunology (Internal Medicine) Physician provider holding M.D. credentials at 250 CETRONIA RD STE 103, ALLENTOWN, PA, 18104, with a listed phone of (610) 841-3890. NPI 1881024891 was issued on 11/13/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ARAKALI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 214 prescription claims written by this provider, covering 57 Medicare beneficiaries and totaling roughly $35K in drug spend, split 29% brand-name and 71% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy & Immunology (Internal Medicine) Physician is a narrow specialty nationwide, with 520 enrolled providers across 48 states and an average of 798 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

250 CETRONIA RD STE 103
ALLENTOWN, PA 18104

Provider Details

NPI 1881024891
Specialty Allergy & Immunology (Internal Medicine) Physician
Credentials M.D.
Gender Female
NPI Issued 11/13/2013

Hospital and facility affiliations

Facilities where SCHWETA ARAKALI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SPECIALTY PHYSICIAN ASSOCIATES, LLC
BETHLEHEM, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SCHWETA ARAKALI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.4K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to SCHWETA ARAKALI, M.D.. To verify SCHWETA ARAKALI, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

SCHWETA ARAKALI, M.D. — brand share 29.0%
Specialty average (est.)

29% brand-name claims vs 71% generic, on 214 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

214
Total Claims
$35K
Total Drug Cost
57
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
323
Total Day Supply
8,862
Brand vs Generic
29% brand / 71% generic
Brand Drug Cost
$29K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
0.92
Gender Split
75% female / 25% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Montelukast Sodium
44
Ipratropium Bromide
32
Fluticasone Propionate
15
Symbicort
Budesonide/Formoterol Fumarate
13
Qvar Redihaler
Beclomethasone Dipropionate
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology (Internal Medicine) Physician Overview

How SCHWETA ARAKALI, M.D. fits within the Allergy & Immunology (Internal Medicine) Physician landscape nationally.

520
Allergy & Immunology (Internal Medicine) Physician Providers in US
48
States with Allergy & Immunology (Internal Medicine) Physician
798
Avg Claims per Provider

SCHWETA ARAKALI, M.D.'s 214 claims are below the specialty average of 798.

Nearby Allergy & Immunology (Internal Medicine) Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as ARAKALI.

Compare Allergy & Immunology (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SCHWETA ARAKALI, M.D.'s specialty?
SCHWETA ARAKALI, M.D. specializes in Allergy & Immunology (Internal Medicine) Physician and practices in ALLENTOWN, Pennsylvania. Credentials: M.D..
How much does SCHWETA ARAKALI, M.D. prescribe under Medicare Part D?
In 2023, SCHWETA ARAKALI, M.D. wrote 214 Medicare Part D claims totaling $35K in drug costs for 57 beneficiaries.
Where is SCHWETA ARAKALI, M.D. located?
SCHWETA ARAKALI, M.D. is located at 250 CETRONIA RD STE 103, ALLENTOWN, PA, 18104. Phone: (610) 841-3890.
What is SCHWETA ARAKALI, M.D.'s NPI number?
SCHWETA ARAKALI, M.D.'s National Provider Identifier (NPI) is 1881024891, issued on 11/13/2013.
Does SCHWETA ARAKALI, M.D. prescribe more brand-name or generic drugs?
SCHWETA ARAKALI, M.D.'s prescribing is 29% brand-name and 71% generic drugs by claim count, with $29K in brand drug costs.
How many Allergy & Immunology (Internal Medicine) Physician providers are there in the US?
There are 520 Allergy & Immunology (Internal Medicine) Physician providers across 48 states in the US. The average Allergy & Immunology (Internal Medicine) Physician provider writes 798 Medicare Part D claims per year.
What drugs does SCHWETA ARAKALI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SCHWETA ARAKALI, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Ipratropium Bromide, Fluticasone Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SCHWETA ARAKALI, M.D. accept Medicare?
SCHWETA ARAKALI, M.D. appears in CMS Medicare data with 214 Part D claims and 57 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SCHWETA ARAKALI, M.D.'s credentials?
SCHWETA ARAKALI, M.D.'s NPI is 1881024891 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology